Featured in this edition of iSpeak Reading Roundup are the top blog posts from April 2019. See key industry topics, membership experiences, and more for what the pharmaceutical industry was reading last month.
ISPE has launched unlimited access for members to a brand-new webinar series including presentations from industry experts on crucial topics of interest in pharma manufacturing. Learn how to gain access to the upcoming series.
ICH Q12 is a quasi-management-based regulatory guideline that will impact facilities and product processing due to the addition of requirements for industry manufacturers. Find out how industry leaders can best prepare for the future of pharma regulation.
Global Day of the Engineer offers the opportunity for all types of engineers to be recognized for the innovative designs and equipment they create, especially for the pharma industry. Hear why engineers are proud to be leaders in the industry.
Explore the three-part series on new water distillation technology and how it will impact production and quality control. Cost control and end-product quality are key initiatives addressed in this technology overview.
See how young professionals can benefit from ISPE membership through networking, mentorship, and education events. ISPE focuses on encouraging career growth and individual skill development for future industry leaders.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...